Rachael Rostas
Primary Care · Mobile, ALNPI 1942666391
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Novo Nordisk at 32.7% of the total. Reporting peaked in 2021 at $1,756 and has fallen 98.0% since, to $35 in 2025.
Across 258 payments — averaging $13.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$453
- Abbott$448
- Lilly USA, LLC$254
- Amarin Pharma, Inc.$199
- AstraZeneca$173
- plus $753 from 21 others
What the payments were for
- Food & beverage$3,386100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 94 | $1,107 |
| AbbVie | 25 | $453 |
| Abbott | 23 | $448 |
| Lilly USA, LLC | 20 | $254 |
| Amarin Pharma, Inc. | 37 | $199 |
| AstraZeneca | 9 | $173 |
| Boehringer Ingelheim | 9 | $126 |
| Johnson & Johnson | 7 | $105 |
| Corcept Therapeutics | 3 | $62 |
| Novartis | 4 | $58 |
| Merck | 4 | $57 |
| Boston Scientific | 3 | $56 |
| Eisai Inc. | 2 | $36 |
| Bayer | 3 | $35 |
| Pfizer | 2 | $25 |
| Bausch Health US, LLC | 2 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| GSK | 1 | $22 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Mannkind Corporation | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $12 |
| Esperion Therapeutics, Inc. | 1 | $12 |
| Amgen | 1 | $12 |
| Biohaven Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,386 in reported general payments places this provider in the 80th percentile of 159 primary care providers in Alabama.
Other primary care in Mobile
- Brandy McGrawMobile$14K
- Joshua RiversMobile$7K
- Barbara NamanMobile$4K
- Tiffany FolseMobile$2K
- Tara ChildersMobile$2K
- Kimberly OchabMobile$1K
- Keith MatthewsOpelika$20K
- Troy HendersonFultondale$18K
- April TateDothan$16K
- Cleo ValdezHuntsville$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.